NECTAR LIFESCIENCES   
                    
                    
                                                         
                                
                                                                 Back to All Ratios 
                                                
                     | 
                        
                        
                        
                        
                    
NECTAR LIFESCIENCES Last 5 Year Core EBITDA Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Core EBITDA Margin(%) | -1.55 | 7.87 | 3.03 | 8.23 | 5.75 | 
What is the latest Core EBITDA Margin ratio of NECTAR LIFESCIENCES ?
| Year | Core EBITDA Margin | 
|---|---|
| Mar2025 | -1.55 | 
| Mar2024 | 7.87 | 
| Mar2023 | 3.03 | 
| Mar2022 | 8.23 | 
| Mar2021 | 5.75 | 
How is Core EBITDA Margin of NECTAR LIFESCIENCES Trending?
| Years | Core EBITDA Margin | % Change | |
|---|---|---|---|
| Mar2025 | -1.55 | Negative | |
| Mar2024 | 7.87 | 159.74 | |
| Mar2023 | 3.03 | -63.18 | |
| Mar2022 | 8.23 | 43.13 | |
| Mar2021 | 5.75 | - | |
Other Financial Ratios of NECTAR LIFESCIENCES
| Operational &  Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate  | Margin  Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin  | Performance  Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales  | Efficiency  Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days  | Valuation  Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales  | Growth  Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth  | Financial Stability  Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap  | 
Compare Core EBITDA Margin ratio of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹317.6 Cr | -2.3% | 4.9% | -54.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 1.2% | 4.4% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 5.8% | 19.2% | 16.3% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -3.7% | -0.2% | 1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | 1.4% | 1.8% | 10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -7.3% | -4% | -6.1% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| NECTAR LIFESCIENCES |    -2.3%  | 
                            
                     
                     4.9%  | 
                     
                     -54.5%  | 
                    
| SENSEX |    -1.4%  |    
                      
                    
                     3.1%  | 
                     
                     3.8%  | 
                    
You may also like the below Video Courses